The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1359
ISSUE 1359
March 7, 2011
Issue 1359
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
In Brief: FDA Warning on Dronedarone (Multaq)
March 7, 2011 (Issue: 1359)
The FDA and the manufacturer (Sanofi-Aventis) have warned healthcare professionals that use of dronedarone (Multaq), an analog of amiodarone (Cordarone, and others) approved in 2009 for treatment of atrial fibrillation,1,2 has been associated with...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.